BioCentury | Nov 3, 2008
Finance

Venture debt demands equity

...in every case, both SkinMedica and Cytori check that box. SkinMedica markets multiple products, including Desonate...
BioCentury | Oct 21, 2008
Financial News

SkinMedica gets $27.5M credit facility

...a $5 million revolving credit line. SkinMedica markets four pharmaceutical and multiple cosmeceutical products, including Desonate...
BioCentury | Feb 19, 2007
Company News

Galderma, SkinMedica sales and marketing update

...The companies launched SkinMedica's Desonate desonide gel 0.05% in the U.S. to treat mild to moderate...
BioCentury | Feb 12, 2007
Clinical News

Desonate: Phase III data

...Pooled data from 2 double-blind Phase III trials in 582 patients showed that twice-daily Desonate for...
...for 4 weeks met all primary (p<0.001) and secondary (p<=0.006) endpoints vs. hydrogel vehicle treatment. Desonate-treated...
...body surface area as early as week 2. At the end of treatment, 58% of Desonate-treated...
BioCentury | Nov 13, 2006
Company News

SkinMedica, Galderma sales and marketing update

...SkinMedica and Galderma's Galderma Laboratories unit will co-promote SkinMedica's Desonate desonide gel 0.05% in the U.S...
BioCentury | Oct 30, 2006
Clinical News

Desonate regulatory update

...FDA approved an NDA for SkinMedica's Desonate desonide gel 0.05% to treat mild to moderate atopic...
...of next year. Dow Pharmaceutical Sciences , Petaluma, Calif. SkinMedica Inc. , Carlsbad, Calif. Product: Desonate...
BioCentury | Jun 26, 2006
Clinical News

Desonate regulatory update

...for Desonate 0.05% desonide gel to treat atopic dermatitis. SkinMedica Inc. , Carlsbad, Calif. Product: Desonate...
Items per page:
1 - 7 of 7